Erasca Stock 715%. Here’s Why One Biotech Fund Still Bets More
A major biotech fund boosted its Erasca stake after a monumental rise. This article unpacks the logic, risks, and tak...
Knowing the best age to start your retirement plan can greatly impact your savings. Explore optimal timing for your financial goals.
20,553 articlesA major biotech fund boosted its Erasca stake after a monumental rise. This article unpacks the logic, risks, and tak...
Ecopetrol sits at the crossroads of a volatile energy market and a growing emerging markets economy. This deep dive b...
Nvidia's latest earnings moment features a clear signal from Jensen Huang about AI demand and strategic momentum. Thi...
Investors are buzzing about SpaceX and a potential IPO that could push the company toward a $2 trillion valuation. Th...
Chevron reported a year-over-year drop in earnings, even as production rose. This article breaks down why, what it me...
As KB unveils its Q1 2026 results, investors will parse revenue signals, margin dynamics, and guidance. This guide br...
A federal injunction blocks a DeSantis-led plan to let recreational anglers fish with fewer federal limits, even as a...
A steep rally has many investors wondering if Intel is a steal or a trap. This guide breaks down the 168% swing in 20...
A high-profile leadership overhaul at CBS News exposes the risks of aggressively rewriting a legacy brand as audience...
PowerFleet is reshaping fleet management with AI-powered IoT. This guide breaks down what to expect from powerfleet (...
A major shift in early trading set the tone for Accenture's latest results. This article explains why accenture stock...
Medicare's first round of drug-price negotiations slashes list prices on 10 widely used drugs by up to 79% starting J...